PositiveID Corporation’s New Generation Health Link Personal Health Record Designed to be First PHR to Communicate Seamless Real-Time Blood Sugar Readings for Diabetics and Their Caregivers/Physicians

DELRAY BEACH, Fla.--(BUSINESS WIRE)--PositiveID Corporation ("PositiveID" or the “Company”) (NASDAQ: PSID) announced today that its new generation Health Link personal health record (PHR) is designed to be the first PHR to provide real-time blood sugar readings for diabetics, and their caregivers/physicians. The Company intends to integrate its Health Link PHR with its iGlucose system, which uses wireless SMS messaging to automatically communicate a diabetic’s glucose levels in real-time.

As the Company expands the capabilities and interoperability of Health Link, it intends to integrate the existing iGlucose online database and data center into the Health Link PHR, which will be interoperable with Microsoft HealthVault and Google Health. The iGlucose system, consisting of a compact data logger and wireless transmitter, currently collects, records and transmits a patient’s glucose readings from a data-capable glucose meter to the iGlucose online database. The integration of iGlucose and the Health Link PHR, will give diabetics the ability to manage their disease unlike ever before. Diabetic patients, parents, physicians and other caregivers will be able to configure Health Link to set specific alerts and alarms related to real-time glucose readings. These alarms could alert the diabetic, parent, caregiver or physician to a high or low glucose reading and allow for real-time management and any necessary action to prevent a potential emergency medical situation.

Scott R. Silverman, Chairman and CEO of PositiveID, said, “As we look to increase the power and features of our first-of-a-kind PHR, Health Link, through the integration of our new iGlucose product, we believe we will be able to help diabetic patients more effectively manage their disease through real-time communication of glucose readings, which can be shared with physicians, caregivers and others. This unique feature will continue to differentiate Health Link from other personal health records in the marketplace as more patients go online to manage their health information.”

According to a November 2009 study by researchers at the University of Chicago published in the journal Diabetes Care, the number of diabetics in the U.S., which currently stands at 23.7 million, may almost double in 25 years, and the annual cost of treating them may triple to $336 billion.

About PositiveID Corporation

PositiveID Corporation develops and markets healthcare and information management products through its RFID-based diagnostic devices and identification technologies, and its proprietary disease management tools. PositiveID operates in two main divisions: HealthID and ID Security. For more information on PositiveID, please visit www.PositiveIDCorp.com.

Statements about PositiveID’s future expectations, including the likelihood that is Health Link is designed to be the first PHR to provide seamless real-time blood sugar readings for diabetics, and their caregivers/physicians, the Company’s ability to integrate the existing iGlucose online database and data center into the Health Link PHR, which will be interoperable with Microsoft HealthVault and Google Health, the capabilities of Health Link, the ability of the integration of iGlucose and the Health Link PHR to give diabetics the ability to manage their disease unlike ever before, the ability of diabetic patients, parents, physicians and other caregivers to configure Health Link to set specific alerts and alarms related to real-time glucose readings, the ability of Health Link, through the integration of the Company’s new iGlucose product, to help diabetic patients more effectively manage their diabetes and the likelihood that this feature will differentiate Health Link from other personal health records in the marketplace, the likelihood that the number of diabetics will almost double in 25 years and the annual cost of treating them will triple to $336 billion, and all other statements in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include the capabilities of Health Link and Health Link’s interoperability; as well as certain other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on February 12, 2009, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.